Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 1/2000

01-01-2000

Cyclin D1 overexpression in a model of human breast premalignancy: preferential stimulation of anchorage-independent but not anchorage-dependent growth is associated with increased cdk2 activity

Authors: Qun Zhou, Julia Wulfkuhle, Taoufik Ouatas, Paula Fukushima, Maryalice Stetler-Stevenson, Fred R. Miller, Patricia S. Steeg

Published in: Breast Cancer Research and Treatment | Issue 1/2000

Login to get access
Metadata
Title
Cyclin D1 overexpression in a model of human breast premalignancy: preferential stimulation of anchorage-independent but not anchorage-dependent growth is associated with increased cdk2 activity
Authors
Qun Zhou
Julia Wulfkuhle
Taoufik Ouatas
Paula Fukushima
Maryalice Stetler-Stevenson
Fred R. Miller
Patricia S. Steeg
Publication date
01-01-2000
Publisher
Kluwer Academic Publishers
Published in
Breast Cancer Research and Treatment / Issue 1/2000
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1023/A:1006370603147

Other articles of this Issue 1/2000

Breast Cancer Research and Treatment 1/2000 Go to the issue

OriginalPaper

The influence of infiltrating lobular carcinoma on the outcome of patients treated with breast-conserving surgery and radiation therapy

OriginalPaper

Overexpression of the glucose-regulated stress gene GRP78 in malignant but not benign human breast lesions

OriginalPaper

Announcement - Cancer Care in the Community Course Announced

OriginalPaper

The axillary arch of Langer – The most common muscular variation in the axilla

OriginalPaper

Course Announcement

OriginalPaper

Eradication of murine mammary adenocarcinoma through HSVtk expression directed by the glucose-starvation inducible grp78 promoter
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits